Friday, October 7, 2016
"EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case"
"The federal government
said this week that
Mylan had been told multiple times that it was improperly classifying the EpiPen, which led the Medicaid and Medicare programs to overpay for the product"